<VariationArchive VariationID="371541" VariationName="NM_005562.3(LAMC2):c.146_150dup (p.Phe51fs)" VariationType="Duplication" Accession="VCV000371541" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2017-01-06" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357010" VariationID="371541">
      <GeneList>
        <Gene Symbol="LAMC2" FullName="laminin subunit gamma 2" GeneID="3918" HGNC_ID="HGNC:6493" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q25.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183186264" stop="183258968" display_start="183186264" display_stop="183258968" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183155173" stop="183214261" display_start="183155173" display_stop="183214261" Strand="+" />
          </Location>
          <OMIM>150292</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005562.3(LAMC2):c.146_150dup (p.Phe51fs)</Name>
      <CanonicalSPDI>NC_000001.11:183207945:AATGGA:AATGGAATGGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q25.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="183207945" stop="183207946" display_start="183207945" display_stop="183207946" variantLength="5" positionVCF="183207945" referenceAlleleVCF="T" alternateAlleleVCF="TAATGG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="183177080" stop="183177081" display_start="183177080" display_stop="183177081" variantLength="5" positionVCF="183177080" referenceAlleleVCF="T" alternateAlleleVCF="TAATGG" />
      </Location>
      <ProteinChange>F51fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.183177082_183177086dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.183177082_183177086dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.183207947_183207951dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.183207947_183207951dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007079.2" sequenceAccession="NG_007079" sequenceVersion="2" change="g.26684_26688dup">
            <Expression>NG_007079.2:g.26684_26688dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005562.3" sequenceAccession="NM_005562" sequenceVersion="3" change="c.146_150dup" MANESelect="true">
            <Expression>NM_005562.3:c.146_150dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005553.2" sequenceAccession="NP_005553" sequenceVersion="2" change="p.Phe51fs">
            <Expression>NP_005553.2:p.Phe51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018891.3" sequenceAccession="NM_018891" sequenceVersion="3" change="c.146_150dup">
            <Expression>NM_018891.3:c.146_150dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_061486.2" sequenceAccession="NP_061486" sequenceVersion="2" change="p.Phe51fs">
            <Expression>NP_061486.2:p.Phe51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16040675" DB="ClinGen" />
        <XRef Type="rs" ID="1057517353" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005562.3(LAMC2):c.146_150dup (p.Phe51fs) AND Junctional epidermolysis bullosa gravis of Herlitz" Accession="RCV000409895" Version="2">
        <ClassifiedConditionList TraitSetID="2421">
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-10-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005562.3(LAMC2):c.146_150dup (p.Phe51fs) AND not provided" Accession="RCV001850972" Version="3">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005562.3(LAMC2):c.146_150dup (p.Phe51fs) AND LAMC2-related disorder" Accession="RCV003392226" Version="4">
        <ClassifiedConditionList TraitSetID="90691">
          <ClassifiedCondition>LAMC2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-14" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-01-06" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11907499</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90691" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70599" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">LAMC2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LAMC2-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="2421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="950899" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="440051|OMIM:226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000487149" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005562.2:c.146_150dup5</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7684698" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="33854356|LAMC2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004112482" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The LAMC2 c.146_150dup5 variant is predicted to result in a frameshift and premature protein termination (p.Phe51Metfs*60). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0015% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-183177080-T-TAATGG). Frameshift variants in LAMC2 are expected to be pathogenic. This variant is interpreted as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005562.2:c.146_150dup5</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LAMC2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4251557" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14526073|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002237074" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11907499</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe51Metfs*60) in the LAMC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMC2 are known to be pathogenic (PMID: 11907499, 16473856). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with LAMC2-related conditions. ClinVar contains an entry for this variant (Variation ID: 371541). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.183177080_183177081insAATGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="950899" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7684698" TraitType="Disease" MappingType="Name" MappingValue="LAMC2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="LAMC2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4251557" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

